USUBJID,AESEQ,AESTDT,AESTDY,AEENDT,AEENDY,AETERM,AEDECOD,AEBODSYS,AESER,AEONGO,AESEV,AEREL,AEOUT,STUDYFL,TRTEMFL,SITE,SITEID,AGE,SEX,RACE,ARM,ARMCD,SBJTSTAT,RFSTDTC,RFENDTC,RFENDY,SAFFL
01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y
01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y
01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y
01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y
01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y
01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y
01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y
01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y
01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y
01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y
01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y
01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y
01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y
01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y
01-701-1028,1,2013-07-21,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y
01-701-1028,1,2013-07-21,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y
01-701-1028,2,2013-08-08,21,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y
01-701-1028,2,2013-08-08,21,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y
01-701-1034,1,2014-08-27,58,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y
01-701-1034,1,2014-08-27,58,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y
01-701-1034,2,2014-11-02,125,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y
01-701-1034,2,2014-11-02,125,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y
01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y
01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y
01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y
01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y
01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y
01-701-1118,1,2003,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,52,M,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-09-09,NA,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y
01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y
01-701-1153,2,2013-10-13,21,2013-11-06,45,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-04-01,147,Y
01-701-1153,2,2013-10-13,21,2013-11-06,45,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-04-01,147,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y
01-701-1181,1,2013-12-09,5,2013-12-09,5,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-05,2013-12-12,4,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y
01-701-1203,1,2013-03-21,48,2013-03-21,48,EYE LASER SURGERY,EYE LASER SURGERY,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-02-02,2013-08-03,136,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y
01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y
01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y
01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y
01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y
01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y
01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y
01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y
01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y
01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y
01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y
01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y
01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y
01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y
01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y
01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y
01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y
01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y
01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y
01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y
01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y
01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y
01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y
01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y
01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y
01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y
01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y
01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y
01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y
01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y
01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y
01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y
01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y
01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y
01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y
01-701-1387,1,2014-03-18,7,2014-03-18,7,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y
01-701-1387,1,2014-03-18,7,2014-03-18,7,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y
01-701-1387,2,2014-03-18,7,2014-03-18,7,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y
01-701-1387,2,2014-03-18,7,2014-03-18,7,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y
01-701-1392,2,2013-03-16,140,2013-03-21,145,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,78,M,WHITE,Placebo,Pbo,ONGOING,2012-10-28,2013-04-28,39,Y
01-701-1392,2,2013-03-16,140,2013-03-21,145,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,78,M,WHITE,Placebo,Pbo,ONGOING,2012-10-28,2013-04-28,39,Y
01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y
01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y
01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y
01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y
01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y
01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y
01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y
01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y
01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y
01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y
01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y
01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y
01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y
01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y
01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y
01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y
01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y
01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y
01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y
01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y
01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y
01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y
01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y
01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y
01-701-1442,1,2014-01-10,77,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-26,2014-04-26,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y
01-703-1042,1,2013-03-04,3,2013-03-05,4,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,180,Y
01-703-1042,1,2013-03-04,3,2013-03-05,4,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,180,Y
01-703-1042,2,2013-03-05,4,2013-03-06,5,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,179,Y
01-703-1042,2,2013-03-05,4,2013-03-06,5,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,179,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y
01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y
01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y
01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y
01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y
01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y
01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y
01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y
01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y
01-703-1175,1,2013-12-18,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,75,M,WHITE,Placebo,Pbo,ONGOING,2013-12-20,2013-12-31,NA,Y
01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y
01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y
01-703-1295,1,2013-12-28,38,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,88,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-21,2014-05-19,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y
01-703-1335,2,2014-03-15,-2,2014-03-30,14,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,67,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-17,2014-05-24,56,Y
01-703-1335,2,2014-03-15,-2,2014-03-30,14,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,67,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-17,2014-05-24,56,Y
01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y
01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y
01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y
01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y
01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y
01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y
01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y
01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y
01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y
01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y
01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y
01-703-1439,1,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y
01-703-1439,1,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y
01-703-1439,2,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y
01-703-1439,2,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y
01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y
01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y
01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y
01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y
01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y
01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y
01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y
01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y
01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y
01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y
01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y
01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y
01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y
01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y
01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y
01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y
01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y
01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y
01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y
01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y
01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y
01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y
01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y
01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y
01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y
01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y
01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y
01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y
01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y
01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y
01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y
01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y
01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y
01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y
01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y
01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y
01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y
01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y
01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y
01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y
01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y
01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y
01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y
01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y
01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y
01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y
01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y
01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y
01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y
01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y
01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y
01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y
01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y
01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y
01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y
01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y
01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y
01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y
01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y
01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y
01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y
01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y
01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y
01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y
01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y
01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y
01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y
01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y
01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y
01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y
01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y
01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y
01-704-1218,1,2012-12-30,42,NA,NA,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-19,2013-05-27,NA,Y
01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y
01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y
01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y
01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y
01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y
01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y
01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y
01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y
01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y
01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y
01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y
01-704-1325,1,2014-05-23,31,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y
01-704-1325,1,2014-05-23,31,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y
01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y
01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y
01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y
01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y
01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y
01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y
01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y
01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y
01-704-1388,1,2012-08-23,-106,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-07,2013-06-19,NA,Y
01-704-1435,1,2013-01-06,51,NA,NA,PARKINSON'S DISEASE,PARKINSON'S DISEASE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,M,WHITE,Placebo,Pbo,ONGOING,2012-11-17,2013-01-12,NA,Y
01-704-1445,1,2014-10-31,174,2014-10-31,174,COMPLETED SUICIDE,COMPLETED SUICIDE,PSYCHIATRIC DISORDERS,N,N,SEVERE,N,FATAL,Y,Y,704,704,75,M,WHITE,Placebo,Pbo,ONGOING,2014-05-11,2014-11-01,2,Y
01-705-1031,1,2013-12-25,29,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-27,2014-05-11,NA,Y
01-705-1059,1,2013-11-02,90,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,66,F,WHITE,Placebo,Pbo,ONGOING,2013-08-05,2013-12-05,NA,Y
01-705-1186,1,2014-01-26,19,NA,NA,HYPERBILIRUBINAEMIA,HYPERBILIRUBINAEMIA,HEPATOBILIARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,84,F,WHITE,Placebo,Pbo,ONGOING,2014-01-08,2014-02-07,NA,Y
01-705-1199,2,2013-09-17,2,2013-09-29,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-09-29,0,Y
01-705-1199,2,2013-09-17,2,2013-09-29,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-09-29,0,Y
01-705-1280,1,2014-04-20,94,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-17,2014-07-25,NA,Y
01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y
01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y
01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y
01-705-1292,1,2013-10-28,15,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y
01-705-1292,1,2013-10-28,15,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y
01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y
01-705-1310,1,2013-11-14,13,NA,NA,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y
01-705-1310,1,2013-11-14,13,NA,NA,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y
01-705-1310,2,2014-01-09,69,NA,NA,WOUND HAEMORRHAGE,WOUND HAEMORRHAGE,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y
01-705-1310,2,2014-01-09,69,NA,NA,WOUND HAEMORRHAGE,WOUND HAEMORRHAGE,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y
01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y
01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y
01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y
01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y
01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y
01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y
01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y
01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y
01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y
01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y
01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y
01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y
01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y
01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y
01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y
01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y
01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y
01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y
01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y
01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y
01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y
01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y
01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y
01-705-1431,1,2013-06-22,-1,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,NA,Y
01-705-1431,1,2013-06-22,-1,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y
01-706-1049,1,2013-06-03,21,2013-06-03,21,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,23,Y
01-706-1049,1,2013-06-03,21,2013-06-03,21,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,23,Y
01-706-1049,2,2013-06-18,36,2013-06-18,36,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,8,Y
01-706-1049,2,2013-06-18,36,2013-06-18,36,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,8,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y
01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y
01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y
01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y
01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y
01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y
01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y
01-708-1032,1,2013-02-26,18,2013-03-09,29,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,62,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-09,2013-03-09,0,Y
01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y
01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y
01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y
01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y
01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y
01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y
01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y
01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y
01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y
01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y
01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y
01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y
01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y
01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y
01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y
01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y
01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y
01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y
01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y
01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y
01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y
01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y
01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y
01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y
01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y
01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y
01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y
01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y
01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y
01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y
01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y
01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y
01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y
01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y
01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y
01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y
01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y
01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y
01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y
01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y
01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y
01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y
01-708-1158,1,2014-02-25,18,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,NA,Y
01-708-1158,1,2014-02-25,18,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,NA,Y
01-708-1158,2,2014-03-22,43,2014-03-22,43,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,0,Y
01-708-1158,2,2014-03-22,43,2014-03-22,43,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,0,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y
01-708-1213,2,2013-02-22,14,2013-02-22,14,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-09,2013-02-26,5,Y
01-708-1213,2,2013-02-22,14,2013-02-22,14,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-09,2013-02-26,5,Y
01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y
01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y
01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y
01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y
01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y
01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y
01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y
01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y
01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y
01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y
01-708-1316,1,2014-01-29,160,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y
01-708-1316,1,2014-01-29,160,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y
01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y
01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y
01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y
01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y
01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y
01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y
01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y
01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y
01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y
01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y
01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y
01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y
01-708-1372,1,2013-04-10,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-12,2013-05-10,NA,Y
01-708-1406,2,2014-06-16,173,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,71,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-26,2014-07-02,NA,Y
01-708-1406,2,2014-06-16,173,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,71,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-26,2014-07-02,NA,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y
01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y
01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y
01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y
01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y
01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y
01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y
01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y
01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y
01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y
01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y
01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y
01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y
01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y
01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y
01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y
01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y
01-709-1081,1,2014-04-07,80,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y
01-709-1081,1,2014-04-07,80,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y
01-709-1088,1,2014-05-08,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y
01-709-1088,1,2014-05-08,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y
01-709-1088,2,2014-08-02,113,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y
01-709-1088,2,2014-08-02,113,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y
01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y
01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y
01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y
01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y
01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y
01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y
01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y
01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y
01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y
01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y
01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y
01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y
01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y
01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y
01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y
01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y
01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y
01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y
01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y
01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y
01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y
01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y
01-709-1301,1,2013-08-30,43,NA,NA,DIABETES MELLITUS,DIABETES MELLITUS,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,62,F,WHITE,Placebo,Pbo,ONGOING,2013-07-19,2014-01-17,NA,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y
01-709-1312,1,2014-05-17,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y
01-709-1312,1,2014-05-17,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y
01-709-1312,2,2014-10-19,183,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y
01-709-1312,2,2014-10-19,183,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y
01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y
01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y
01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y
01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y
01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y
01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y
01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y
01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y
01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y
01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y
01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y
01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y
01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y
01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y
01-709-1339,1,2011-11,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y
01-709-1339,1,2011-11,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y
01-709-1424,1,2013-03-07,5,2013-03-07,5,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline High Dose,Xan_Hi,DISCONTINUED,2013-03-03,2013-03-08,2,Y
01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y
01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y
01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y
01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y
01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y
01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y
01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y
01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y
01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y
01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y
01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y
01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y
01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y
01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y
01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y
01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y
01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y
01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y
01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y
01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y
01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y
01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y
01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y
01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y
01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y
01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y
01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y
01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y
01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y
01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y
01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y
01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y
01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y
01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y
01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y
01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y
01-710-1083,1,2013-08-02,12,2013-08-02,12,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,FATAL,Y,Y,710,710,89,F,WHITE,Placebo,Pbo,ONGOING,2013-07-22,2013-08-03,2,Y
01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y
01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y
01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y
01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y
01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y
01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y
01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y
01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y
01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y
01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y
01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y
01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y
01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y
01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y
01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y
01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y
01-710-1183,1,2014-03-10,115,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y
01-710-1183,1,2014-03-10,115,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y
01-710-1187,1,2012-12-23,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-10,2013-05-12,NA,Y
01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y
01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y
01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y
01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y
01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y
01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y
01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y
01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y
01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y
01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y
01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y
01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y
01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y
01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y
01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y
01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y
01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y
01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y
01-710-1270,1,2014-02-23,12,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y
01-710-1270,1,2014-02-23,12,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y
01-710-1270,2,2014-02-23,12,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y
01-710-1270,2,2014-02-23,12,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y
01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y
01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y
01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y
01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y
01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y
01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y
01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y
01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y
01-710-1314,2,2013-05-20,27,2013-05-24,31,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,78,F,WHITE,Placebo,Pbo,ONGOING,2013-04-24,2013-05-25,2,Y
01-710-1314,2,2013-05-20,27,2013-05-24,31,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,78,F,WHITE,Placebo,Pbo,ONGOING,2013-04-24,2013-05-25,2,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y
01-710-1354,1,2012-12-30,50,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y
01-710-1354,1,2012-12-30,50,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y
01-710-1354,2,2013-02-14,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y
01-710-1354,2,2013-02-14,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y
01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y
01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y
01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y
01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y
01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y
01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y
01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y
01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y
01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y
01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y
01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y
01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y
01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y
01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y
01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y
01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y
01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y
01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y
01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y
01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y
01-713-1073,1,2014-07-14,107,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-30,2014-10-05,NA,Y
01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y
01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y
01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y
01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y
01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y
01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y
01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y
01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y
01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y
01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y
01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y
01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y
01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y
01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y
01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y
01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y
01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y
01-714-1425,1,2013-08-13,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,714,714,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-22,NA,Y
01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y
01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y
01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y
01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y
01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y
01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y
01-715-1207,1,2013-01-10,54,2013-01-10,54,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,78,F,WHITE,Placebo,Pbo,ONGOING,2012-11-18,2013-06-01,143,Y
01-715-1319,1,2013-03-18,30,2013-03-18,30,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-03-18,0,Y
01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y
01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y
01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y
01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y
01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y
01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y
01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y
01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y
01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y
01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y
01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y
01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y
01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y
01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y
01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y
01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y
01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y
01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y
01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y
01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y
01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y
01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y
01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y
01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y
01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y
01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y
01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y
01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y
01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y
01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y
01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y
01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y
01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y
01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y
01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y
01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y
01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y
01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y
01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y
01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y
01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y
01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y
01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y
01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y
01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y
01-716-1108,1,2013-04-12,60,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y
01-716-1108,1,2013-04-12,60,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y
01-716-1108,2,2013-05-01,79,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y
01-716-1108,2,2013-05-01,79,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y
01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y
01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y
01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y
01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y
01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y
01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y
01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y
01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y
01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y
01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y
01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y
01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y
01-716-1160,1,2013-05-09,35,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y
01-716-1160,1,2013-05-09,35,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y
01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y
01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y
01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y
01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y
01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y
01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y
01-716-1177,1,2014-08-24,-9,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,716,716,72,M,WHITE,Placebo,Pbo,ONGOING,2014-09-02,2015-03-05,NA,Y
01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y
01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y
01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y
01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y
01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y
01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y
01-716-1308,1,2013-09-20,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,76,F,WHITE,Placebo,Pbo,ONGOING,2013-08-28,2013-10-07,NA,Y
01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y
01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y
01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y
01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y
01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y
01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y
01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y
01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y
01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y
01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y
01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y
01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y
01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y
01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y
01-716-1364,1,2013-08-18,46,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y
01-716-1364,1,2013-08-18,46,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y
01-716-1373,1,2012-12-14,1,NA,NA,COGNITIVE DISORDER,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y
01-716-1373,1,2012-12-14,1,NA,NA,COGNITIVE DISORDER,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y
01-716-1373,2,2012-12-15,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y
01-716-1373,2,2012-12-15,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y
01-716-1441,1,2014-05-11,110,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Placebo,Pbo,ONGOING,2014-01-22,2014-07-22,NA,Y
01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y
01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y
01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y
01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y
01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y
01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y
01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y
01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y
01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y
01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y
01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y
01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y
01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y
01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y
01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y
01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y
01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y
01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y
01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y
01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y
01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y
01-717-1201,1,2013-12-19,1,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y
01-717-1201,1,2013-12-19,1,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y
01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y
01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y
01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y
01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y
01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y
01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y
01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y
01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y
01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y
01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y
01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y
01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y
01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y
01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y
01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y
01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y
01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y
01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y
01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y
01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y
01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y
01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y
01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y
01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y
01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y
01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y
01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y
01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y
01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y
01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y
01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y
01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y
01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y
01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y
01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y
01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y
01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y
01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y
01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y
01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y
01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y
01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y
01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y
01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y
01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y
01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y
01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y
01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y
01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y
01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y
01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y
01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y
01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y
01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y
01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y
01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y
01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y
01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y
01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y
01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y
01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y
01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y
01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y
01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y
01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y
01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y
01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y
01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y
01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y
01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y
01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y
01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y
01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y
01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y
01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y
01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y
01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y
01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y
01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y
01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y
01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y
01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y
